No evidence of association between common European mitochondrial DNA variants in Alzheimer, Parkinson, and migraine in the Spanish population

American Journal of Medical Genetics, Part B: Neuropsychiatric Genetics

Volumn 168, Issue 1, 2015, Pages 54-65

  Fachal, Laura ^a   Mosquera Miguel, Ana ^b   Pastor, Pau ^c,d,e   Ortega Cubero, Sara ^c,e   Lorenzo, Elena ^c,e   Oterino Durán, Agustín ^f   Toriello, María ^f   Quintáns, Beatriz ^a   Camiña Tato, Montse ^a   Sesar, Angel ^g   Vega, Ana ^a   Sobrido, María Jesús ^a   Salas, Antonio ^b  

^a CENTRO DE INVESTIGACIÓN BIOMÉDICA EN RED DE ENFERMEDADES RARAS CIBERER   (Spain)

^b UNIVERSITY OF SANTIAGO DE COMPOSTELA   (Spain)

^c UNIVERSITY OF NAVARRA   (Spain)

^d UNIVERSITY CLINIC OF NAVARRA   (Spain)

^e INSTITUTO DE SALUD CARLOS III   (Spain)

^f HOSPITAL UNIVERSITARIO MARQUÉS DE VALDECILLA   (Spain)

^g University Hospital of Santiago de Compostela   (Spain)

Author keywords

Alzheimer disease; Association studies; False positive; Migraine; Mitochondrial DNA; Parkinson disease; Population stratification; SNPs

Indexed keywords

MITOCHONDRIAL DNA;

ALZHEIMER DISEASE; ARTICLE; COHORT ANALYSIS; CONTROLLED STUDY; DISEASE ASSOCIATION; FALSE POSITIVE RESULT; FEMALE; GENETIC ASSOCIATION; GENETIC VARIABILITY; HUMAN; MAJOR CLINICAL STUDY; MALE; MIGRAINE; MITOCHONDRIAL HAPLOGROUP; PARKINSON DISEASE; PHYLOGENY; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM; SPAIN; GENETIC PREDISPOSITION; GENETICS; MITOCHONDRION;

ALZHEIMER DISEASE; DNA, MITOCHONDRIAL; FEMALE; GENETIC ASSOCIATION STUDIES; GENETIC PREDISPOSITION TO DISEASE; HUMANS; MALE; MIGRAINE DISORDERS; MITOCHONDRIA; PARKINSON DISEASE; POLYMORPHISM, SINGLE NUCLEOTIDE; SPAIN;

EID: 84919430547     PISSN: 15524841     EISSN: 1552485X     Source Type: Journal    
DOI: 10.1002/ajmg.b.32276     Document Type: Article

References (86)

1. Achilli A, Perego UA, Bravi CM, Coble MD, Kong QP, Woodward SR, Salas A, Torroni A, Bandelt H-J. 2008. The phylogeny of the four pan-American MtDNA haplogroups: Implications for evolutionary and disease studies. PLoS ONE 3(3):e1764.
2. Álvarez-Iglesias V, Mosquera-Miguel A, Cerezo M, Quintáns B, Zarrabeitia MT, Cuscó I, Lareu MV, García O, Pérez-Jurado L, Carracedo Á, Salas A. 2009. New population and phylogenetic features of the internal variation within mitochondrial DNA macro-haplogroup R0. PLoS ONE 4(4):e5112.
3. Andrews RM, Kubacka I, Chinnery PF, Lightowlers RN, Turnbull DM, Howell N. 1999. Reanalysis and revision of the Cambridge reference sequence for human mitochondrial DNA. Nat Genet 23(2):147.
4. Bandelt H-J, Kong Q-P, Parson W, Salas A. 2005. More evidence for non-maternal inheritance of mitochondrial DNA. J Med Genet 42:957-960.
5. Bandelt H-J, Salas A. 2009. Contamination and sample mix-up can best explain some patterns of mtDNA instabilities in buccal cells and oral squamous cell carcinoma. BMC Cancer 9(1):113.
6. Campion D, Dumanchin C, Hannequin D, Dubois B, Belliard S, Puel M, Thomas-Anterion C, Michon A, Martin C, Charbonnier F, Raux G, Camuzat A, Penet C, Mesnage V, Martinez M, Clerget-Darpoux F, Brice A, Frebourg T. 1999. Early-onset autosomal dominant Alzheimer disease: Prevalence, genetic heterogeneity, and mutation spectrum. Am J Hum Genet 65(3):664-670.
7. Carrieri G, Bonafe M, De Luca M, Rose G, Varcasia O, Bruni A, Maletta R, Nacmias B, Sorbi S, Corsonello F, Feraco E, Andreev KF, Yashin AI, Franceschi C, De Benedictis G. 2001. Mitochondrial DNA haplogroups and APOE4 allele are non-independent variables in sporadic Alzheimer's disease. Hum Genet 108(3):194-198.
8. Catelli ML, Álvarez-Iglesias V, Gómez-Carballa A, Mosquera-Miguel A, Romanini C, Borosky A, Amigo J, Carracedo Á, Vullo C, Salas A. 2011. The impact of modern migrations on present-day multi-ethnic Argentina as recorded on the mitochondrial DNA genome. BMC Genet 12:77.
9. Cerezo M, Černý V, Carracedo Á, Salas A. 2009. Applications of MALDI-TOF MS to large-scale human mtDNA population-based studies. Electrophoresis 30(21):3665-3673.
10. Cervantes S, Samaranch L, Vidal-Taboada JM, Lamet I, Bullido MJ, Frank-García A, Coria F, Lleo A, Clarimon J, Lorenzo E, Alonso E, Sánchez-Juan P, Rodríguez-Rodríguez E, Combarros O, Rosich M, Vilella E, Pastor P. 2011. Genetic variation in APOE cluster region and Alzheimer's disease risk. Neurobiol Aging 32(11):e2107-e2117.
11. Chagnon P, Gee M, Filion M, Robitaille Y, Belouchi M, Gauvreau D. 1999. Phylogenetic analysis of the mitochondrial genome indicates significant differences between patients with Alzheimer disease and controls in a French-Canadian founder population. Am J Med Genet 85(1):20-30.
12. Chinnery PF. 1993. Mitochondrial disorders overview. In: Pagon RA, Adam MP, Ardinger HH, Bird TD, Dolan CR, Fong CT, Smith RJH, Stephens K, editors. GeneReviews(R). Seattle (WA).
13. Chinnery PF, Elliott HR, Syed A, Rothwell PM. 2010. Mitochondrial DNA haplogroups and risk of transient ischaemic attack and ischaemic stroke: A genetic association study. Lancet Neurol 9(5):498-503.
14. Clark J, Reddy S, Zheng K, Betensky RA, Simon DK. 2011. Association of PGC-1alpha polymorphisms with age of onset and risk of Parkinson's disease. BMC Med Genet 12:69.
15. Coskun P, Wyrembak J, Schriner SE, Chen HW, Marciniack C, Laferla F, Wallace DC. 2012. A mitochondrial etiology of Alzheimer and Parkinson disease. Biochim Biophys Acta 1820(5):553-564.
16. Coto E, Gómez J, Alonso B, Corao AI, Díaz M, Menéndez M, Martínez C, Calatayud MT, Moris G, Álvarez V. 2011. Late-onset Alzheimer's disease is associated with mitochondrial DNA 7028C/haplogroup H and D310 poly-C tract heteroplasmy. Neurogenetics 12(4):345-346.
17. Dexter DT, Jenner P. 2013. Parkinson disease: From pathology to molecular disease mechanisms. Free Radic Biol Med 62:132-144.
18. Dhillon VS, Fenech M. 2014. Mutations that affect mitochondrial functions and their association with neurodegenerative diseases. Muta Res Rev Muta Res 759:1-13.
19. Edland SD, Silverman JM, Peskind ER, Tsuang D, Wijsman E, Morris JC. 1996. Increased risk of dementia in mothers of Alzheimer's disease cases: Evidence for maternal inheritance. Neurol 47(1):254-256.
20. Egensperger R, Kosel S, Schnopp NM, Mehraein P, Graeber MB. 1997. Association of the mitochondrial tRNA (A4336G) mutation with Alzheimer's and Parkinson's diseases. Neuropathol Appl Neurobiol 23(4):315-321.
21. Elson JL, Herrnstadt C, Preston G, Thal L, Morris CM, Edwardson JA, Beal MF, Turnbull DM, Howell N. 2006. Does the mitochondrial genome play a role in the etiology of Alzheimer's disease. Hum Genet 119(3):241-254.
22. Fachal L, Mosquera-Miguel A, Gómez-Caamano A, Sánchez-García M, Calvo P, Lobato-Busto R, Salas A, Vega A. 2014. Evaluating the role of mitochondrial DNA variation to the genetic predisposition to radiation-induced toxicity. Radiother Oncol 111(2):199-205.
23. Finnilä S, Autere J, Lehtovirta M, Hartikainen P, Mannermaa A, Soininen H, Majamaa K. 2001. Increased risk of sensorineural hearing loss and migraine in patients with a rare mitochondrial DNA variant 4336A>G in tRNAGln. J Med Genet 38(6):400-405.
24. Gaweda-Walerych K, Maruszak A, Safranow K, Bialecka M, Klodowska-Duda G, Czyzewski K, Slawek J, Rudzinska M, Styczynska M, Opala G, Drozdzik M, Canter JA, Barcikowska M, Zekanowski C. 2008. Mitochondrial DNA haplogroups and subhaplogroups are associated with Parkinson's disease risk in a Polish PD cohort. J Neural Transm 115(11):1521-1526.
25. Ghezzi D, Marelli C, Achilli A, Goldwurm S, Pezzoli G, Barone P, Pellecchia MT, Stanzione P, Brusa L, Bentivoglio AR, Bonuccelli U, Petrozzi L, Abbruzzese G, Marchese R, Cortelli P, Grimaldi D, Martinelli P, Ferrarese C, Garavaglia B, Sangiorgi S, Carelli V, Torroni A, Albanese A, Zeviani M. 2005. Mitochondrial DNA haplogroup K is associated with a lower risk of Parkinson's disease in Italians. Eur J Hum Genet 13(6):748-752.
26. Gómez-Carballa A, Cerezo M, Balboa E, Heredia C, Castro-Feijóo L, Rica I, Barreiro J, Eirís J, Cabanas P, Martínez-Soto I, Fernández-Toral J, Castro-Gago M, Pombo M, Carracedo Á, Barros F, Salas A. 2011. Evolutionary analyses of entire genomes does not support the association of mtDNA mutations with Ras/MAPK pathway syndromes. PLoS ONE 6(4):e18348.
27. Gómez-Carballa A, Olivieri A, Behar DM, Achilli A, Torroni A, Salas A. 2012. Genetic continuity in the Franco-Cantabrian region: New clues from autochthonous mitogenomes. PLoS ONE 7(3):e32851.
28. Herrnstadt C, Howell N. 2004. An evolutionary perspective on pathogenic mtDNA mutations: Haplogroup associations of clinical disorders. Mitochondrion 4(5-6):791-798.
29. Howell N, Elson JL, Chinnery PF, Turnbull DM. 2005. MtDNA mutations and common neurodegenerative disorders. Trends Genet 21(11):583-586.
30. Hudson G, Nalls M, Evans JR, Breen DP, Winder-Rhodes S, Morrison KE, Morris HR, Williams-Gray CH, Barker RA, Singleton AB, Hardy J, Wood NE, Burn DJ, Chinnery PF. 2013. Two-stage association study and meta-analysis of mitochondrial DNA variants in Parkinson disease. Neurology 80(22):2042-2048.
31. Hudson G, Sims R, Harold D, Chapman J, Hollingworth P, Gerrish A, Russo G, Hamshere M, Moskvina V, Jones N, Thomas C, Stretton A, Holmans PA, O'Donovan MC, Owen MJ, Williams J, Chinnery PF. 2012. No consistent evidence for association between mtDNA variants and Alzheimer disease. Neurology 78(14):1038-1042.
32. Huerta C, Castro MG, Coto E, Blázquez M, Ribacoba R, Guisasola LM, Salvador C, Martínez C, Lahoz CH, Álvarez V. 2005. Mitochondrial DNA polymorphisms and risk of Parkinson's disease in Spanish population. J Neurol Sci 236(1):49-54.
33. Hughes AJ, Daniel SE, Kilford L, Lees AJ. 1992. Accuracy of clinical diagnosis of idiopathic Parkinson's disease: A clinico-pathological study of 100 cases. J Neurol Neurosurg Psychiatry 55(3):181-184.
34. Hutchin T, Cortopassi G. 1995. A mitochondrial DNA clone is associated with increased risk for Alzheimer disease. Proc Natl Acad Sci USA 92(15):6892-6895.
35. Ioannidis JP. 2005. Why most published research findings are false. PLoS Med 2(8):e124.
36. Kang L, Lee ST, Im W, Kim SC, Hun KS, Kim BK, Kim M. 2007. Screening of the A11084G polymorphism and scanning of a mitochondrial genome SNP in Korean migraineurs. J Clin Neurol 3(3):127-132.
37. Krüger J, Hinttala R, Majamaa K, Remes AM. 2010. Mitochondrial DNA haplogroups in early-onset Alzheimer's disease and frontotemporal lobar degeneration. Mol Neurodegener 5:8.
38. Lakatos A, Derbeneva O, Younes D, Keator D, Bakken T, Lvova M, Brandon M, Guffanti G, Reglodi D, Saykin A, Weiner M, Macciardi F, Schork N, Wallace DC, Potkin SG. 2010. Association between mitochondrial DNA variations and Alzheimer's disease in the ADNI cohort. Neurobiol Aging 31(8):1355-1363.
39. Latsoudis H, Spanaki C, Chlouverakis G, Plaitakis A. 2008. Mitochondrial DNA polymorphisms and haplogroups in Parkinson's disease and control individuals with a similar genetic background. J Hum Genet 53(4):349-356.
40. Lesage S, Brice A. 2009. Parkinson's disease: From monogenic forms to genetic susceptibility factors. Hum Mol Genet 18(R1):R48-R59.
41. Macarthur D. 2012. Methods: Face up to false positives. Nature 487(7408):427-428.
42. Mahley RW, Weisgraber KH, Huang Y. 2006. Apolipoprotein E4: A causative factor and therapeutic target in neuropathology, including Alzheimer's disease. Proc Natl Acad Sci USA 103(15):5644-5651.
43. Majamaa K, Moilanen JS, Uimonen S, Remes AM, Salmela PI, Karppa M, Majamaa-Voltti KA, Rusanen H, Sorri M, Peuhkurinen KJ, Hassinen IE. 1998. Epidemiology of A3243G, the mutation for mitochondrial encephalomyopathy, lactic acidosis, and strokelike episodes: Prevalence of the mutation in an adult population. Am J Hum Genet 63(2):447-454.
44. Mancuso M, Calsolaro V, Orsucci D, Carlesi C, Choub A, Piazza S, Siciliano G. 2009. Mitochondria, cognitive impairment, and Alzheimer's disease. Int J Alz Dis DOI: 10.4061/2009/951548.
45. Mancuso M, Nardini M, Micheli D, Rocchi A, Nesti C, Giglioli NJ, Petrozzi L, Rossi C, Ceravolo R, Bacci A, Choub A, Ricci G, Tognoni G, Manca ML, Siciliano G, Murri L. 2007. Lack of association between mtDNA haplogroups and Alzheimer's disease in Tuscany. Neurol Sci 28(3):142-147.
46. Marcheco-Teruel B, Parra EJ, Fuentes-Smith E, Salas A, Buttenschon HN, Demontis D, Torres-Español M, Marín-Padrón LC, Gómez-Cabezas EJ, Álvarez-Iglesias V, Mosquera-Miguel A, Martínez-Fuentes A, Carracedo Á, Borglum AD, Mors O. 2014. Cuba: exploring the history of admixture and the genetic basis of pigmentation using autosomal and uniparental markers. PLoS Genet 10(7):e1004488.
47. Martikainen MH, Majamaa K. 2010. Epidemiology and characteristics of occipital brain infarcts in young adults in southwestern Finland. J Neurol 257(2):259-263.
48. Maruszak A, Canter JA, Styczyńska M, Zekanowski C, Barcikowska M. 2009. Mitochondrial haplogroup H and Alzheimer's disease-Is there a connection. Neurobiol Aging 30(11):1749-1755.
49. McKhann G, Drachman D, Folstein M, Katzman R, Price D, Stadlan EM. 1984. Clinical diagnosis of Alzheimer's disease: Report of the NINCDS-ADRDA work group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology 34(7):939-944.
50. Mehta P, Mellick GD, Rowe DB, Halliday GM, Jones MM, Manwaring N, Vandebona H, Silburn PA, Wang JJ, Mitchell P, Sue CM. 2009. Mitochondrial DNA haplogroups J and K are not protective for Parkinson's disease in the Australian community. Mov Disord 24(2):290-292.
51. Montagna P. 2000. Molecular genetics of migraine headaches: A review. Cephalalgia 20(1):3-14.
52. Mortimer MJ, Kay J, Jaron A, Good PA. 1992. Does a history of maternal migraine or depression predispose children to headache and stomach-ache. Headache 32(7):353-355.
53. Mosquera-Miguel A, Torrell H, Abasolo N, Arrojo M, Paz E, Ramos-Ríos R, Agra S, Páramo M, Brenlla J, Martínez S, Vilella E, Valero J, Gutiérrez-Zotes A, Martorell L, Costas J, Salas A. 2012. No evidence that major mtDNA European haplogroups confer risk to schizophrenia. Am J Med Genet B Neuropsychiatr Genet 159B(4):414-421.
54. Nicholls DG, Budd SL. 2000. Mitochondria and neuronal survival. Physiol Rev 80(1):315-360.
55. Ojaimi J, Katsabanis S, Bower S, Quigley A, Byrne E. 1998. Mitochondrial DNA in stroke and migraine with aura. Cerebrovasc Dis 8(2):102-106.
56. Otaegui D, Paisan C, Saenz A, Marti I, Ribate M, Marti-Masso JF, Perez-Tur J, Lopez de Munain. 2004. Mitochondrial polymporphisms in Parkinson's Disease. Neurosci Lett 370(2-3):171-174.
57. Pala M, Achilli A, Olivieri A, Kashani BH, Perego UA, Sanna D, Metspalu E, Tambets K, Tamm E, Accetturo M, Carossa V, Lancioni H, Panara F, Zimmermann B, Huber H, Al-Zahery N, Brisighelli F, Woodward SR, Francalacci P, Parson W, Salas A, Behar DM, Villems R, Semino O, Bandelt H-J, Torroni A. 2009. Mitochondrial haplogroup U5b3: A distant echo of the epipaleolithic in Italy and the legacy of the early Sardinians. Am J Hum Genet 84(6):814-821.
58. Pardo-Seco J, Amigo J, González-Manteiga W, Salas A. 2013. A generalized model to estimate the statistical power in mitochondrial disease studies involving 2×k tables. PLoS ONE 8(9):e73567.
59. Polymeropoulos MH, Higgins JJ, Golbe LI, Johnson WG, Ide SE, Di Iorio G, Sanges G, Stenroos ES, Pho LT, Schaffer AA, Lazzarini AM, Nussbaum RL, Duvoisin RC. 1996. Mapping of a gene for Parkinson's disease to chromosome 4q21-q23. Science 274(5290):1197-1199.
60. Pyle A, Foltynie T, Tiangyou W, Lambert C, Keers SM, Allcock LM, Davison J, Lewis SJ, Perry RH, Barker R, Burn DJ, Chinnery PF. 2005. Mitochondrial DNA haplogroup cluster UKJT reduces the risk of PD. Ann Neurol 57(4):564-567.
61. Raule N, Sevini F, Santoro A, Altilia S, Franceschi C. 2007. Association studies on human mitochondrial DNA: Methodological aspects and results in the most common age-related diseases. Mitochondrion 7(1-2):29-38.
62. Richards MB, Macaulay VA, Bandelt H-J, Sykes BC. 1998. Phylogeography of mitochondrial DNA in western Europe. Ann Hum Genet 62:241-260.
63. Ridge PG, Ebbert MT, Kauwe JS. 2013. Genetics of Alzheimer's disease. BioMed Res Int 2013:254954.
64. Ridge PG, Maxwell TJ, Corcoran CD, Norton MC, Tschanz JT, O'Brien E, Kerber RA, Cawthon RM, Munger RG, Kauwe JS. 2012. Mitochondrial genomic analysis of late onset Alzheimer's disease reveals protective haplogroups H6A1A/H6A1B: The Cache County Study on Memory in Aging. PLoS ONE 7(9):e45134.
65. Ross OA, McCormack R, Maxwell LD, Duguid RA, Quinn DJ, Barnett YA, Rea IM, El-Agnaf OM, Gibson JM, Wallace A, Middleton D, Curran MD. 2003. Mt4216C variant in linkage with the mtDNA TJ cluster may confer a susceptibility to mitochondrial dysfunction resulting in an increased risk of Parkinson's disease in the Irish. Exp Gerontol 38(4):397-405.
66. Rozen TD, Shanske S, Otaegui D, Lu J, Young WB, Bradley K, DiMauro S, Silberstein SD. 2004. Study of mitochondrial DNA mutations in patients with migraine with prolonged aura. Headache 44(7):674-677.
67. Salas A, Comas D, Lareu MV, Bertranpetit J, Carracedo A. 1998. MtDNA analysis of the Galician population: A genetic edge of European variation. Eur J Hum Genet 6(4):365-375.
68. Salas A, Elson JL. 2012. Raising doubts about the pathogenicity of mitochondrial DNA mutation m.3308T>C in left ventricular hypertraveculation/noncompaction. Cardiol 122(2):113-115.
69. Salas A, Fachal L, Marcos-Alonso S, Vega A, Martinón-Torres F. 2009a. Investigating the role of mitochondrial haplogroups in genetic predisposition to meningococcal disease. PLoS ONE 4(12):e8347.
70. Salas A, Lareu V, Calafell F, Bertranpetit J, Carracedo Á. 2000. MtDNA hypervariable region II (HVII) sequences in human evolution studies. Eur J Hum Genet 8(12):964-974.
71. Salas A, Yao Y-G, Macaulay V, Vega A, Carracedo Á, Bandelt H-J. 2005a. A critical reassessment of the role of mitochondria in tumorigenesis. PLoS Med 2(11):e296.
72. Santoro A, Balbi V, Balducci E, Pirazzini C, Rosini F, Tavano F, Achilli A, Siviero P, Minicuci N, Bellavista E, Mishto M, Salvioli S, Marchegiani F, Cardelli M, Olivieri F, Nacmias B, Chiamenti AM, Benussi L, Ghidoni R, Rose G, Gabelli C, Binetti G, Sorbi S, Crepaldi G, Passarino G, Torroni A, Franceschi C. 2010. Evidence for sub-haplogroup h5 of mitochondrial DNA as a risk factor for late onset Alzheimer's disease. PLoS ONE 5(8):e12037.
73. Shoffner JM, Brown MD, Torroni A, Lott MT, Cabell MF, Mirra SS, Beal MF, Yang CC, Gearing M, Salvo R, et al. 1993. Mitochondrial DNA variants observed in Alzheimer disease and Parkinson disease patients. Genomics 17(1):171-184.
74. Simon DK, Mayeux R, Marder K, Kowall NW, Beal MF, Johns DR. 2000. Mitochondrial DNA mutations in complex I and tRNA genes in Parkinson's disease. Neurol 54(3):703-709.
75. Soares P, Ermini L, Thomson N, Mormina M, Rito T, Röhl A, Salas A, Oppenheimer S, Macaulay V, Richards MB. 2009. Correcting for purifying selection: An improved human mitochondrial molecular clock. Am J Hum Genet 84(6):740-759.
76. Sparaco M, Feleppa M, Lipton RB, Rapoport AM, Bigal ME. 2006. Mitochondrial dysfunction and migraine: Evidence and hypotheses. Cephalalgia 26(4):361-372.
77. Stovner LJ, Zwart JA, Hagen K, Terwindt GM, Pascual J. 2006. Epidemiology of headache in Europe. Eur J Neurol 13(4):333-345.
78. Strimmer K. 2008. Fdrtool: A versatile R package for estimating local and tail area-based false discovery rates. Bioinformatics 24(12):1461-1462.
79. Strittmatter WJ, Saunders AM, Schmechel D, Pericak-Vance M, Enghild J, Salvesen GS, Roses AD. 1993. Apolipoprotein E: High-avidity binding to beta-amyloid and increased frequency of type 4 allele in late-onset familial Alzheimer disease. Proc Natl Acad Sci USA 90(5):1977-1981.
80. Swerdlow RH, Weaver B, Grawey A, Wenger C, Freed E, Worrall BB. 2006. Complex I polymorphisms, bigenomic heterogeneity, and family history in Virginians with Parkinson's disease. J Neurol Sci 247(2):224-230.
81. van der Walt JM, Dementieva YA, Martin ER, Scott WK, Nicodemus KK, Kroner CC, Welsh-Bohmer KA, Saunders AM, Roses AD, Small GW, Schmechel DE, Murali Doraiswamy, Gilbert P, Haines JR, Vance JL, Pericak-Vance JM. 2004. Analysis of European mitochondrial haplogroups with Alzheimer disease risk. Neurosci Lett 365(1):28-32.
82. van der Walt JM, Nicodemus KK, Martin ER, Scott WK, Nance MA, Watts RL, Hubble JP, Haines JL, Koller WC, Lyons K, Pahwa R, Stern MB, Colcher A, Hiner BC, Jankovic J, Ondo WG, Allen FH, Jr., Goetz CG, Small GW, Mastaglia F, Stajich JM, McLaurin AC, Middleton LT, Scott BL, Schmechel DE, Pericak-Vance MA, Vance JM. 2003. Mitochondrial polymorphisms significantly reduce the risk of Parkinson disease. Am J Hum Genet 72(4):804-811.
83. Yan MH, Wang X, Zhu X. 2013. Mitochondrial defects and oxidative stress in Alzheimer disease and Parkinson disease. Free Radic Biol Med 62:90-101.
84. Yao Y-G, Kong Q-P, Salas A, Bandelt H-J. 2008. Pseudo-mitochondrial genome haunts disease studies. J Med Genet 45(12):769-772.
85. Yorns WR, Jr., Hardison HH. 2013. Mitochondrial dysfunction in migraine. Seminars in pediatric neurology. Semin Pediatr Neurol 20(3):188-119.
86. Zaki EA, Freilinger T, Klopstock T, Baldwin EE, Heisner KR, Adams K, Dichgans M, Wagler S, Boles RG. 2009. Two common mitochondrial DNA polymorphisms are highly associated with migraine headache and cyclic vomiting syndrome. Cephalalgia 29(7):719-728.